Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Published:2017-03 Issue:3 Volume:31 Page:396-410
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Seckinger Anja,Delgado Jose Antonio,Moser Samuel,Moreno Laura,Neuber Brigitte,Grab Anna,Lipp Susanne,Merino Juana,Prosper Felipe,Emde Martina,Delon Camille,Latzko Melanie,Gianotti Reto,Lüoend Remo,Murr Ramona,Hosse Ralf J.,Harnisch Lydia Jasmin,Bacac Marina,Fauti Tanja,Klein Christian,Zabaleta Aintzane,Hillengass Jens,Cavalcanti-Adam Elisabetta Ada,Ho Anthony D.,Hundemer Michael,San Miguel Jesus F.,Strein Klaus,Umaña Pablo,Hose Dirk,Paiva Bruno,Vu Minh Diem

Funder

EngMab AG

German Federal Ministry of Education

Deutsche Forschungsgemeinschaft

Cooperative Research Thematic Network

Instituto de Salud Carlos III

Asociación Española Contra el Cáncer

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference43 articles.

1. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016

2. A novel carcinoembryonic antigen T-cell bispecific antibody (CEA TCB) for the treatment of solid tumors;Bacac;Clin. Cancer Res.,2016

3. Novel immunotherapies in lymphoid malignancies;Batlevi;Nat. Rev. Clin. Oncol.,2016

4. Epidemiology of multiple myeloma;Becker;Recent Results Cancer Res.,2011

5. Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor;Bellucci;Blood,2005

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibodies in the treatment of multiple myeloma;Blood Cancer Journal;2024-09-12

2. ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells;Nature Cancer;2024-09-11

3. T-cell redirecting bispecific antibody treatment in multiple myeloma: current knowledge and future strategies for sustained T-cell engagement;Expert Opinion on Biological Therapy;2024-09

4. Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation;JCO Precision Oncology;2024-07

5. Update of antibody–drug conjugates for hematological malignancies;Current Opinion in Oncology;2024-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3